Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of FETO in CDH Phase III

NCT07187206 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT07187206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07187206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of FETO in CDH Phase III
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 3
Overall status
Recruiting
Start date
September 30, 2025
Completion date
March 1, 2033
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital diaphragmatic hernia, pulmonary hypertension, pulmonary hypoplasia